
VEXAS syndrome is a newly described adult-onset autoinflammatory disorder, predominantly affecting males (median age, 68), and recognized by somatic mutations in the UBA1 gene in blood-forming cells of the X chromosome. This rare disease causes systemic inflammation and abnormalities in the blood, with high morbidity and mortality when untreated.
VEXAS syndrome has been defined by mutations in the UBA1 gene and represents a rare but life-threatening condition affecting mainly men over the age of 50. Thus, early diagnosis of VEXAS is critical, since there is no prevention, and it probably has an overlap with other inflammatory conditions concerning signs and symptoms. Making the diagnosis early on may ease symptoms and ultimately prolong survival with timely diagnosis, appropriate treatment with steroids or immunosuppressants, or definitive therapy with a continued option of allogeneic bone marrow transplant. This is the most exciting area of research with new therapies, so education about this condition and timely interventions for at-risk patients is paramount.
Disclaimer- This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a healthcare provider for diagnosis or treatment of any medical condition.
Shubhi is a seasoned content writer with 6 years of experience in digital media. Specializing in news, lifestyle, health, sports, space, optical illusions, and trending topics, she crafts engaging, SEO-friendly content that informs and captivates readers. Passionate about storytelling, Shubhi blends accuracy with creativity to deliver impactful articles across diverse domains.
Iran holds a state funeral in Tehran for top officials Ali Larijani and Gholamreza Soleimani,…
SOMANY Ceramics Continues to Build Upon Its Waste Tile Reuse Initiative on Global Recycling Day 2026
New Delhi [India], March 18: On the occasion of Global Recycling Day, SOMANY Ceramics is looking back…
The teaser for Spider-Man: Brand New Day reveals a darker, more intense story with Tom…